Good news from the field of research with regard to osteoporosis was invented a very exciting new treatment that promises to slow down and mitigate the trouble of osteoporosis is very normal for women after menopause, in fact it is nearly a wanted procedure unluckily which must be kept under strict manage through supplements and food very targeted. This new medicine is known and Denosumab is a monoclonal antibody that acts against osteoclasts, which are the cells that dismantle the bone.

The Denosumab is given by injection under the skin, the dose is 60 mg and is done every 6 months, and then I would tell that it is not very committed or for physicians or for patients, we anticipation the drug is not aching but it is a fracture definitely much more. The learn was conducted on a sample of 7,800 women and 1,400 men who were suffering from post-menopausal osteoporosis and prostate cancer without metastases, the data were brilliant, 60% of fractures off! We anticipation that this drug shall soon be accessible to all.